Comparison of long-term clinical outcomes among zotarolimus-, everolimus-, and biolimus-eluting stents in acute myocardial infarction patients with renal impairment

BACKGROUND: It is important to determine the best drug-eluting stent (DES) for acute myocardial infarction (AMI) in patients with renal impairment. In this studythe outcomes of everolimus-eluting stents (EESs), zotarolimus-eluting stents (ZESs) and biolimus-eluting stents (BESs) were evaluated. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Seok, Hyun, Dae Young, Cho, Kyung Hoon, Kim, Ju Han, Jeong, Myung Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2022
Materias:
Clinical Cardiology: Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287071/
https://www.ncbi.nlm.nih.gov/pubmed/34490605
http://dx.doi.org/10.5603/CJ.a2021.0099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287071/
https://www.ncbi.nlm.nih.gov/pubmed/34490605
http://dx.doi.org/10.5603/CJ.a2021.0099

Ejemplares similares